Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Liabilities ₹4,190 Cr₹3,967 Cr₹3,410 Cr₹3,193 Cr₹4,520 Cr

What is the latest Total Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹4,190 Cr based on Mar2026 Consolidated results.
Year Total Liabilities
Mar2026₹4,190 Cr
Mar2025₹3,967 Cr
Mar2024₹3,410 Cr
Mar2023₹3,193 Cr
Mar2022₹4,520 Cr

How is Total Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2026 ₹4,190 Cr
5.62
Mar2025 ₹3,967 Cr
16.33
Mar2024 ₹3,410 Cr
6.80
Mar2023 ₹3,193 Cr
-29.36
Mar2022 ₹4,520 Cr -

Compare Total Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹42,771.0 Cr 0.7% -9.3% -3.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr 2.7% 1.4% 4.3% Stock Analytics
DIVIS LABORATORIES ₹273,565.0 Cr 4.5% 6.3% 50.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,332.0 Cr 1.8% -1.3% 31.4% Stock Analytics
DR REDDYS LABORATORIES ₹114,532.0 Cr 0.8% 12.5% 14.1% Stock Analytics
CIPLA ₹113,831.0 Cr 1.6% 4.4% -9.1% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

0.7%

-9.3%

-3.3%

SENSEX

8.8%

10.9%

-4%


You may also like the below Video Courses